Shares of Novavax Inc. NVAX slid 3.46% to $9.22 Friday, on what proved to be an all-around rough trading session for the ...

Novavax (NVAX) ended the recent trading session at ... Meanwhile, the Dow experienced a rise of 1.65%, and the technology-dominated Nasdaq saw an increase of 2.45%. Coming into today, shares ...

But the company trimmed its outlook. Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant ...

$100,000 of NOVAVAX INC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to COVID-19 vaccines ...

Novavax shares are trading lower by 9.8% during Monday's session. Shares of vaccine stocks are trading lower after Moderna ...

Shares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) have been given a consensus recommendation of “Hold” by the six ratings firms that are covering the firm, Marketbeat reports.

Three of VBK's underlying holdings with notable upside to their analyst target prices are Evolent Health Inc (Symbol: EVH), MediaAlpha Inc (Symbol: MAX), and Novavax, Inc. (Symbol: NVAX).

Dow Jones futures have also gained upside momentum on Inauguration Day. From a big picture point of view, Dow Jones continues ...

Telemedicine Teladoc Health (NYSE: TDOC) and vaccine maker Novavax (NASDAQ: NVAX) belong in this group: Both have significantly lagged behind the market since 2021. Teladoc was a leader in the ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

But the company trimmed its outlook. Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...